Cochlear implantation is generally considered a safe and effective recommendation for healthy adults who have bilateral, moderate-to-severe or moderate-to-profound sensorineural hearing loss and do not benefit from acoustic amplification (i.e., poor speech recognition).
However, given the large elderly population and the importance of timely hearing intervention, there is a need to more closely examine the hearing health-care needs of this population. Hammond-Kenny (2021) at Cambridge University Hospitals conducted a retrospective study to examine the complication rates, survival duration, audiological outcomes, and cost utility of cochlear implants for 126 recipients, ages 80 years and older.
Findings suggest acceptable complication rates and survival durations as well as impressive improvements in thresholds and speech recognition scores that are similar to improvements achieved by younger populations. Their findings suggest that adults of any age should be given equal access to cochlear implantation. Unfortunately, however, equal access is not always guaranteed in the United States.
Miller and colleagues (2020) report that adults with public health insurance (e.g., Medicare) often have to wait longer to receive cochlear implants and may experience poorer postoperative speech-perception outcomes than those with private insurance. Given the significant speech recognition and other benefits achieved by many adults who obtain cochlear implants, a continued focus on equal access, regardless of age and insurance status, is warranted.
Hammond-Kenny A, Borsetto D, Manjaly JG, et al. (2021) Cochlear implantation in elderly patients: survival duration, hearing outcomes, complication rates, and cost utility. Audiol Neurootol In press.
Miller SE, Anderson A, Manning, J Schafer EC. (2020) Insurance payer status predicts postoperative speech outcomes in adult cochlear implant recipients. J Am Acad Audiol 31(9):666–673.
The National Health Service (NHS) is a conglomerate name for the publicly funded health-care system of the United Kingdom (England, Scotland, and Wales). Gentamicin is the first-choice antibiotic if a newborn develops a serious bacterial infection. According to the University of Manchester, approximately 90,000 babies a year in the United Kingdom alone are treated with…
Artificial intelligence (AI) is being used in so many facets of our existence. It is disrupting the status quo and challenging previously held beliefs and systems. From the looks of it, AI’s application in the hearing health-care arena is present and growing. AI use in hearing aids, in particular, is garnering attention outside the field….
Electrical engineer Dr. Lichauan Liu of Northern Illinois University (NIU) has designed technology to prevent hearing loss in newborns who are in the neonatal intensive care unit (NICU). NICUs are noisy places. According to Almadhoob and Ohlsson (2020), sound levels in NICUs range from 7 dB to 120 dB and often exceed the maximum acceptable…